Dr. David W Borowski

Specialist General and Laparoscopic Surgeon / Minimal Access Surgeon

MD FRCS(Ed), FHEA(UK)

Practice Credentials:

Name: Erongo Surgical

HPCNA Number: MPR002370

NAMAF Practice Number: 042 000 0594474

Location:

Welwitschia Hospital, Walvis Bay, Namibia.

Address:

Dr. Putch Harries Drive
P.O. Box 1760
Walvis Bay
Namibia

Contact:

+264 64 270 200 (Erongo Surgical)

+264 64 218 911 (Welwitschia Hospital)

Fax: +264 64 220 939

Patient referrals and enquiries
Surgeon@walvisbay-medipark.com

Reception: Amber Strauss
StraussA@walvisbay-medipark.com

Accounts: Brumilde Oswald
OswaldB@walvisbay-medipark.com

Practice Manager: Whitney De La Harpe
DeLaHarpeW@walvisbay-medipark.com

Clinical Interests & Experience:

David graduated in 1996 from the Heinrich-Heine-University Düsseldorf, Germany. He moved to North-East England, where he completed his residency and core surgical training.

Between 2002 and 2004, David undertook postgraduate doctoral (MD) research at Newcastle University on organisational factors in the management of colorectal cancer. He completed higher surgical training in the Northern Deanery in 2010, including a fellowship in laparoscopic colorectal surgery.

He was appointed as Consultant General & Colorectal Surgeon at the University Hospital North Tees in Stockton-on-Tees in 2011, and was Lead Clinician for undergraduate teaching for students at Newcastle University, as well as Research & Development Lead, until he took up practice as Specialist Surgeon with Erongo Surgical at the Welwitschia Hospital in Walvis Bay, Namibia at the end of 2015.

David provides a broad elective and emergency general surgical service, including thyroid, breast, hernia and other general surgical procedures, including emergency surgery.

His special interest is in gastro-intestinal and colorectal endoscopy and surgery, and proctology. His expertise include the management of diseases in the oesophagus (e.g. endoscopic and surgical management of gastro-oesophageal reflux disease, cancer management), stomach (e.g. peptic ulcer disease, cancer surgery), diseases of the liver, gallbladder and pancreas, appendix, small and large bowel (e.g. polyps, cancer, inflammatory bowel disease, diverticular disease and functional bowel problems such as irritable bowel), and conditions in the anal region (haemorrhoids, fissures, fistulae). He has a broad experience in minimal access techniques, and carries out most of his intra-abdominal procedures.

He has also a keen interest in medical education, including medical students, medical staff, allied health professionals and patients. He is the organiser of the Coastal Continuing Professional Developmemt (CPD) Meeting, a regular forum for interdisciplinary continuing education within the Erongo region.

Qualifications & Certifications:

  • 1996 – State Examination Medicine, Heinrich Heine University, Duesseldorf, Germany
  • 1999 – Advanced Trauma Life Support (ATLS), UK
  • 2001 – Membership of the Royal College of Surgeons of Edinburgh (MRCSEd), UK
  • 2007 – Medical Doctorate (MD), Newcastle University, UK
  • 2009 – Fellowship of the Royal College of Surgeons of Edinburgh (FRCSEd), UK
  • 2010 – Certificate of Completed Specialist Training, General Medical Council, UK
  • 2010 – Joint Advisory Group Certificate for Upper and Lower GI Endoscopy, UK
  • 2012 – Associate Clinical Lecturer, Newcastle University, UK
  • 2013 – Clinical Excellence Award Level I, North Tees & Hartlepool NHS Trust, UK
  • 2013 – Certificate in Medical Education, Newcastle University, UK
  • 2013 – Fellowship of the Higher Education Authority (FHEA), UK
  • 2014 – Honorary Senior Clinical Lecturer, Newcastle University, UK
  • 2015 – Clinical Excellence Award Level II, North Tees & Hartlepool NHS Trust, UK
  • 2017 – Definitive Surgical Trauma Care (DSTC) Provider, Johannesburg, SA
  • 2018 – Small Bowel Capsule Endoscopy (“PillCam”) Provider, Medtronic
  • 2018 – Surgical Trainer Certification (“Train the Trainers”), CoSECSA

More About Dr. David Borowski ...

Publications & Studies:

David has been a prolific researcher in many aspects of surgical practice; he has authored, co-authored and collaborated on more than 40 peer-reviewed and published medical articles to-date, and has presented more than 50 times at national and international conferences.

David has been Chief Investigator of three peer-reviewed, completed and published clinical trials, and Principal Investigator or Collaborator on many multicentre trials and studies.

He is also the author of a chapter in the Oxford Handbook of Operative Surgery: Chapter 1 – General Surgery (2017) 3rd Edition.

Selected Clinical Publications:

  • D.W. Borowski, S.B. Kelly, D.M. Bradburn, R.G. Wilson, A. Gunn, A.A. Ratcliffe and the members of NORCCAG: “The impact of surgeon volume and specialisation on short-term outcomes in colorectal cancer surgery”; British Journal of Surgery (2007), 94(7): 880-889
  • D.W. Borowski, A.A. Ratcliffe, B. Bharathan, A. Gunn, D.M. Bradburn, S.J. Mills, R.G. Wilson, S.B. Kelly and the members of NORCCAG: “Involvement of surgical trainees in surgery for colorectal cancer and their effect on outcome”; Colorectal Disease (2008), 10(8): 837-845
  • D.W. Borowski, M. Knox, V. Kanakala, K. Seymour, S.E. Attwood, B.J. Slater: “Referral Pathways of Patients with Gallstones: A Source of Financial Waste in the UK National Health Service?”; International Journal of Healthcare Quality Assurance (2010), 23(2): 248-257
  • D.W. Borowski, D.M. Bradburn, S.J. Mills, B. Bharathan, R.G. Wilson, A.A. Ratcliffe, S.B. Kelly (for the members of NORCCAG): “Volume-outcome analysis of colorectal-cancer related outcomes and survival”; British Journal of Surgery (2010), 97(9): 1416-1430
  • D. Archampong, D.W. Borowski and H. Dickinson: “Impact of surgeon volume on outcomes of rectal cancer surgery: a systematic review and meta-analysis”; The Surgeon (2010), 8(6): 341-352.
  • S.B. Kelly, D.M. Bradburn, S.J. Mills, A.A. Ratcliffe and D.W. Borowski (for the members of NORCCAG): “Effect of the Circumferential Resection Margin on survival following rectal cancer surgery”; British Journal of Surgery (2011), 98(4): 573-581.
  • B. Bharathan, M. Welfare, D.W. Borowski, S.J. Mills, N. Steen and S.B. Kelly (for the members of NORCCAG): “The impact of deprivation on short and long-term outcomes of patients after surgery for colorectal cancer”; British Journal of Surgery (2011): 98(6): 854-865.
  • V. Kanakala, D.W. Borowski, M.G.C. Pellen, S. Dronamaraju, S.A.A. Woodcock, K. Seymour, S.E. Attwood, L.F. Horgan: “Risk Factors in Laparoscopic Cholecystectomy”; International Journal of Surgery (2011), 9(4): 318-323.
  • D.W. Borowski, V. Kanakala, A.K. Agarwal, M.A. Tabaqchali, D.K. Garg, T.S. Gill: “Single-port access laparoscopic reversal of Hartmann’s operation”; Diseases of the Colon and Rectum (2011), 54(8): 1053-1056.
  • N. Ndukwe, D.W. Borowski, A. Lee, A. Orr, S. Dexter-Smith, A.A. Agarwal: “The ‘two-week rule’ for suspected colorectal cancer: understanding patient experience and psychological impact”; International Journal of Healthcare Quality Assurance (2012), 25(1): 75-85
  • D. Archampong, D.W. Borowski, L.H. Iversen, P. Wille-Jorgenson: “Workload and surgeon’s specialty for outcome after colorectal cancer surgery”; Cochrane Database of Systematic Reviews (2012), 3: CD005391
  • V. Kanakala, D.W. Borowski, A.K. Agarwal, M.A. Tabaqchali, D.K. Garg, T.S. Gill: “Comparative study of safety and outcomes of single-port access versus conventional laparoscopic colorectal surgery”; Techniques in Coloproctology (2012): 16(6): 423-428. doi: 10.1007/s10151-012-0839-0
  • D.W. Borowski, T.S. Gill, A.K. Agarwal, P. Bhaskar: “Autologous adipose-tissue derived regenerative cells for the treatment of complex cryptoglandular fistula-in-ano – A report of three cases”; BMJ Case Reports (2012): doi: 10.1136/bcr-2012-006988
  • D.B. Kovacs, D. Ray, K. Dasgupta, D.W. Borowski: “Intestinal complications of Behcet’s disease”; BMJ Case Reports (2013): doi:10.1136/bcr-2013-200253
  • P. Tozer, D. Borowski, A. Gupta, N. Yassin, R. Phillips, A. Hart:: “Review article: Managing perianal Crohn’s fistula in the anti-TNFα era”; Techniques in Coloproctology (2015): 19(11): 673-678. doi: 10.1007/s10151-015-1332-3
  • D.W. Borowski, S. Zaidi, M. Toward, N. Maguire, S. Cawkwell, T.S. Gill: “Primary care referral practice, variability and socio-economic deprivation in colorectal cancer”; Colorectal Disease (2016): 18(11): 1072-1079. Doi:10.1111/codi.13360
  • D.W. Borowski, S. Zaidi, M. Toward, N. Maguire, S. Cawkwell, T.S. Gill: “Volume-Outcome Relationship for Colorectal Cancer in Primary Care: A Prospective Cohort Study”; International Journal of Healthcare Quality Assurance (2017): 30(5): doi:10.1108/IJHCQA-01-2016-0001
  • D.W. Borowski, S. Zaidi, M. Toward, D.K. Garg, T.S. Gill: “The NHS Bowel cancer screening achieves survival improvement, but participation must be improved”; International Journal of Healthcare Quality Assurance (2018): 31(2): 106-115. doi: https://doi.org/10.1108/IJHCQA-11-2016-0169
  • P. Thambi, D.W. Borowski, R. Sathasivam, R.-B. Obuobi, Y.K.S. Viswanath, T.S. Gill: “Single Incision Laparoscopic Reversal of Hartmann’s operation through the stoma site: comparative outcomes with conventional laparoscopic and open surgery”; Colorectal Disease (2019): 21(7): 833-840. doi:10.1111/codi.14617
  • D.W. Borowski, Y. Lyeschuk: “Two sides of one coin: pan-gastrointestinal Kaposi sarcoma presenting with small bowel intussusception and severe gastrointestinal haemorrhage”; South African Journal of Surgery (2021): 59(1): 10-13. https://doi.org/10.17159/2078-5151/2021/v59n1a3215

Completed and Published Clinical Trials (as Chief Investigator):

  • D.W. Borowski, B. Banky, A.K. Banerjee, A.K. Agarwal, M.A. Tabaqchali, D.K. Garg, C. Hobday, M. Hegab, T.S. Gill: “Intra-arterial Methylene Blue injection into ex-vivo colorectal cancer specimens improves lymph node staging accuracy: a randomised-controlled trial”; Colorectal Disease (2014): 16(9): 681-689. doi:10.1111/codi.12681
  • D.W. Borowski, T.S. Gill, A.K. Agarwal, M.A. Tabaqchali, D.K. Garg and P. Bhaskar: “Adipose tissue-derived regenerative cell-enhanced Lipofilling for treatment of cryptoglandular Fistula-in-Ano: The ALFA technique”, Surgical Innovation (2015): 22(6): 593-600. doi:10.1177/1553350615572656
  • D.W. Borowski, E.A. Baker, D. Wilson, D.K. Garg, T.S. Gill: “Clinical outcomes and inflammatory response to Single-Incision Laparoscopic (SIL) colorectal surgery: a single-blinded randomised-controlled pilot study”; Colorectal Disease (2019): 21(1): 79-89. doi:10.1111/codi.14435

Collaborative Research:

  • CholeS Study Group: “Population-based prospective cohort study of variation in the use of emergency cholecystectomy for benign gallbladder diseases”; British Journal of Surgery (2016): 103(12): 1716-1726.
  • CholeS Study Group: “Population-based cohort study of outcomes following cholecystectomy for benign gallbladder diseases”; British Journal of Surgery (2016): 103(12): 1704-1715.
  • CholeS Study Group: A.J. Sutton, R.S. Vohra, M. Hollyman, P.J. Marriott, A. Buja, D. Alderson, S. Pasquali, E.A. Griffiths on behalf of the CholeS Study Group: “Cost effectiveness of emergency versus delayed laparoscopic cholecystectomy for acute gallbladder pathology”; British Journal of Surgery (2016): doi:10.1002/bjs.10317
  • CholeS Study Group: R.P. Sutcliffe, M. Hollyman, J. Hodson, G. Bonney, R.S. Vohra, E.A. Griffiths on behalf of the CholeS Study Group: “Pre-operative risk factors for conversion from laparoscopic to open cholecystectomy: a validated risk score derived from a prospective UK database of 8820 patients”; HPB (2016): 18: 922-928. doi:10.1016/j.hpb.2016.07.015
  • CholeS Study Group: R. Bharamgoudar, A. Sonsale, J Hodson, E.A. Griffiths on behalf of the CholeS Study Group: “The development and validation of a scoring tool to predict the operative duration of elective laparoscopic cholecystectomy”; Surgical Endoscopy (2018): 32(7): 3149-3157. doi:10.1007/s00464-018-6030-6.
  • CholeS Study Group: E.A. Griffiths, J. Hodson, R.S. Vohra, P. Marriott, T. Katbeh, S. Zino, A.H.M. Nassar: “Utilisation of an operative difficulty grading scale for laparoscopic cholecystectomy”; Surgical Endoscopy (2019): 33(1): 110-121. doi:10.1007/s00464-018-6281-2.
  • CholeS Study Group: A.M. El-Sharkawy, N. Tewari, R.S. Vohra: “The Cholecystectomy as a Day Case (CAAD) Score: A validated score of pre-operative predictors of successful day-case Cholecystectomy using the CholeS data set”; World Journal of Surgery (2019): 43(8): 1928-1934. doi:10.1007/s00268-019-04981-5.
  • CholeS Study Group: A.H.M. Nassar, J. Hodson, H.J. Ng, R.S. Vohra, T. Katbeh, S. Zino, E.A. Griffiths: “Predicting the difficult laparoscopic cholecystectomy: development and validation of a pre-operative risk score using an objective operative difficulty grading system”; Surgical Endoscopy (2019): 34(10): 4549-4561. doi:10.1007/s00464-019-07244-5.
  • DREAMS Trial Collaborators and West Midlands Research Collaborative: “Dexamethasone versus standard treatment for post-operative nausea and vomiting in gastrointestinal surgery: randomised controlled trial (DREAMS Trial); BMJ (2017): 357:j1455: doi: http://dx.doi.org/10.1135/bmj.j1455
  • NIHR Global Health Research Unit on Global Surgery: “Quality and outcomes in global cancer surgery: protocol for a multicentre, international, prospective cohort study (GlobalSurg 3)”; CBMJ Open (2019): 9(5): doi:10.1136/bmjopen-2018-026646
  • NIHR Global Health Research Unit on Global Surgery: “Global variation in postoperative mortality and complications after cancer surgery: a multicentre, international, prospective cohort study in 82 countries (GlobalSurg 3)”; Lancet (2021): 397(10272): 387-397. https://doi.org/10.1016/S0140-6736(21)00001-5.
  • Reinforcement of Closure of Stoma Site (ROCCS) Collaborative and West Midlands Research Collaborative: “Prophylactic biological mesh reinforcement versus standard closure of stoma site (ROCCS): a multicentre, randomised controlled trial”; Lancet (2020): 395(10222): 417-426. Doi:10.1016/S0140-6736(19)32637-6
  • Bach SP, Gilbert A, Brock K, Korsgen S, Geh I, Hill J, Gill T, Hainsworth P, Tutton MG, Khan J, Robinson J, Steward M, Cunningham C, Levy B, Beveridge A, Handley K, Kaur M, Marchevsky N, Magill L, Russell A, Quirke P, West NP, Sebag-Montefiore D & TREC collaborators: „Radical Surgery versus organ preservation via short course radiotherapy followed by transanal endoscopic microsurgery for early-stage rectal cancer (TREC): a randomised, open-label feasibility study“; Lancet Gastroenterology & Hepatology (2021): 6(2): 92-105. Doi: 10.1016/S2468-1253(20)30333-2

Get in touch with Dr. David Borowski

Would you like to book an appointment with Dr Borowski? Fill out the quick form below with your details and he’ll get back to you as soon as he can.